Early-onset Cardiotoxicity assessment related to anthracycline in children with leukemia. A Prospective Study

BACKGROUND: Acute leukemias are the most frequent malignancies in children. Advances in treatment have improved the overall survival to 80%. Almost 10% of children with cancer develop clinical cardiac toxicity. Total anthracycline cumulative dose is a risk factor for early-onset cardiotoxicity. OBJE...

Descripción completa

Detalles Bibliográficos
Autores principales: Linares Ballesteros, Adriana, Sanguino Lobo, Roy, Villada Valencia, Juan Camilo, Arévalo Leal, Oscar, Plazas Hernández, Diana Constanza, Aponte Barrios, Nelson, Perdomo Ramírez, Iván
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Universidad del Valle 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054707/
https://www.ncbi.nlm.nih.gov/pubmed/33911320
http://dx.doi.org/10.25100/cm.v52i1.4542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054707/
https://www.ncbi.nlm.nih.gov/pubmed/33911320
http://dx.doi.org/10.25100/cm.v52i1.4542

Ejemplares similares